NCI's Cancer Biomarkers Study

The NCI's Cancer Biomarkers Study investigates molecules or features in the body—called biomarkers—that can indicate the presence, development, or response to treatment of cancer. By identifying these biomarkers, researchers aim to improve early detection, personalize therapies, and monitor treatment effectiveness. The study involves analyzing samples from cancer patients and healthy individuals to discover patterns that can assist clinicians in making more precise and timely diagnostic and treatment decisions, ultimately advancing cancer care and patient outcomes.